DCGI - GOVERNANCE
News: Rajeev
Singh Raghuvanshi to be new Drugs Controller General of India
What's in the news?
● The
Appointments Committee of the Cabinet has approved the proposal of appointing Dr. Rajeev Singh Raghuvanshi as the
new Drugs Controller General of India (DCGI). Mr. Raghuvanshi, who is the
Secretary and Scientific Director of The Indian Pharmacopoeia Commission (IPC),
has been given the charge of DCGI for a three-year
period ending on February 28, 2025.
DCGI:
● Drugs
Controller General of India is the head of department of the Central Drugs Standard Control Organization
of the Government of India.
Functions under: Ministry of Health &
Family Welfare.
Functions:
● Responsible
for approval of licenses of specified
categories of drugs such as blood and blood products, IV fluids, vaccines,
and sera in India.
● DCGI
also sets standards for
manufacturing, sales, import, and distribution of drugs in India.
● DCGI
will also act as Central Licensing
Authority (CLA) for the medical devices which fall under the purview of
Medical Device Rules, 2017.
● Acting
as appellate authority in case of
any dispute regarding the quality of drugs.
● Preparation
and maintenance of national reference standards for drugs.
● To
bring about uniformity in the enforcement of the Drugs and Cosmetics Act.
● Training
of Drug Analysts deputed by State Drug Control Laboratories and other
institutions.
● Analysis
of Cosmetics received as survey samples from CDSCO (Central Drugs Standard
Control Organization).